Cefrax CV Tablet

Description

CEFRAX CV Tablet is a combination antibiotic manufactured by Cipla Ltd.. It contains Cefixime (a third-generation cephalosporin antibiotic) and Clavulanic Acid (a beta-lactamase inhibitor).

This combination is prescribed for the treatment of resistant bacterial infections affecting the respiratory tract (sinusitis, bronchitis, pneumonia, tonsillitis, pharyngitis), urinary tract infections, ear infections (otitis media), skin and soft tissue infections, and typhoid fever.

• Cefixime works by blocking bacterial cell wall synthesis, leading to bacterial death.

• Clavulanic Acid helps by inhibiting enzymes (beta-lactamases) that certain bacteria produce to resist antibiotics, thereby enhancing the action of Cefixime.

Together, they provide a broader spectrum of antibacterial activity compared to Cefixime alone.

---

Key Benefits of CEFRAX CV:

• Effective against antibiotic-resistant bacterial strains.

• Treats respiratory, urinary, ear, skin, and soft tissue infections.

• Useful in chronic or recurrent infections where single antibiotics may fail.

• Helps prevent treatment failure due to resistance.

---

How to Take:

• Take orally, with or without food (preferably after meals to reduce gastric irritation).

• Swallow with a full glass of water.

• Complete the full prescribed course even if symptoms improve.

---

Precautions:

• Take only under doctor’s supervision.

• Inform your doctor about allergies to cephalosporins, penicillins, or clavulanic acid.

• Use with caution in patients with kidney or liver problems.

• Pregnant or breastfeeding women should use only if clearly advised by a doctor.

---

Possible Side Effects:

• Common: Diarrhea, nausea, vomiting, abdominal pain, indigestion, flatulence, mild rash.

• Rare: Severe allergic reactions, persistent diarrhea (sign of colitis), yellowing of skin/eyes (liver issues).

---

Storage:

• Store in a cool, dry place, away from direct heat and light.

• Keep out of children’s reach